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May 12, 2009:1824–7maging or invasive coronary stenosis pressure measurements (frac-
ional flow reserve), and in particular a significant mismatch between
natomical severity of a stenosis and functional severity of a stenosis
ften occurs in intermediate lesions (5,6). However, increasing the
everity of a stenosis to a cutoff level of 70% will result in a better
greement with myocardial perfusion imaging as suggested by Dr.
icol and colleagues, but the price to be paid is lower sensitivity and
onsequent decrease in negative predictive value, which is considered
of the major strengths of coronary CT imaging. We agree with Dr.
icol and colleagues that more studies are required to define the most
cceptable cutoff level of the severity of a stenosis (50% vs. 70%) either
etermined by visual or automated contour detection algorithms.
Importantly, only scant information is available about the
ole of noninvasive coronary anatomy information as compared
ith functional information obtained by exercise ECG stress
esting, stress echocardiography, or single-photon emission
omputed tomography. It is always difficult for a new diagnostic
odality to establish its role among already available diagnostic
odalities, and it will take time to provide scientific evidence to
emonstrate the diagnostic performance and value of the new
echnique in various clinical situations and even more time to
stablish its cost-effectiveness. Although we are still enthusias-
ic about the potential of coronary CT, we are also aware of the
act that more scientific evidence should become available
efore we can recommend widespread use of this exciting new
iagnostic modality.
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eply
he letter by Drs. Min and Berman proposes that, pending clinical
ffectiveness trials, “common sense should dictate clinical use” of
omputed tomography coronary angiography (CTCA). They fur-
her opine that “with its very high negative predictive value, an
mmediate benefit of the use of this test would be to eliminate the
eed for unnecessary invasive coronary angiography.” In medicine,
common sense” has often been used to justify approaches to
reatment that ultimately did not withstand careful scrutiny.
ommon sense suggested that use of antiarrhythmic agents to
uppress premature ventricular contractions would benefit patients,
hen in fact such therapies produced the opposite result. “Com-
on sense” is not a suitable alternative to rigorous clinical testing.
n a second letter, Dr. Nicol and colleagues also emphasize a
negative predictive value in excess of 90%,” which they state is
nusual in medicine. These authors provide an explanation for the
oor performance of CTCA in the Meijboom et al. (1) study,
hich they attribute to cut points used to define a “significant”
tenosis.
In response, it must be noted that nuclear scintigraphy also has
ery high negative predictive value, exceeding 90% in multiple
igh-quality studies, accompanied by a more favorable positive
redictive value. Both letters seem to miss the principal issues
aised by the editorial (2). First, the high false-positive rate
ssociated with CTCA represents a potential hazard to patients by
timulating unnecessary invasive angiography. The costs associated
ith false-positive studies are substantial, both in economic terms
nd through potential catheterization-related adverse outcomes,
ncluding morbidity from unnecessary interventions driven by the
oculostenotic reflex.” Both sets of writers fail to acknowledge the
ubstantial radiation burden imposed by CTCA and the potential
o induce fatal malignancies, particularly in younger patients.
Even more importantly, the authors of both letters ignore the
ey premise underlying the editorial (2)—that it is not very useful
o merely identify the presence or absence of stenoses. What
linicians need most is reliable information on the extent of
nducible ischemia, data not provided by angiography. CTCA
annot replace current functional testing methods, because CTCA
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May 12, 2009:1824–7rovides only limited anatomic information and does not reveal
hether stenoses are clinically significant. Accordingly, clinicians
ust perform other diagnostic studies to determine whether the
tenoses observed by CTCA are the likely cause of the patient’s
ymptoms. Such serial testing is costly and inefficient. In a
ontemporary environment, where cost-effectiveness must be care-
ully considered, CTCA as currently employed represents a poor
alue compared with other diagnostic procedures.
Functional testing by stress echocardiography or nuclear scin-
igraphy provides greater clinical utility. In addition to identifying
hether flow-limiting lesions are present, the exercise capacity and
agnitude of the ischemic burden provide valuable prognostic
nformation that can be used to guide therapy.
The burden of proof remains with the proponents of CTCA.
hey must demonstrate that this imaging modality provides
uperior value to existing diagnostic methods through meticulous
omparative trials in which clinical performance and cost-
ffectiveness are rigorously measured. Until such studies are com-leted, CTCA should be viewed as a research tool and not a
linically proven diagnostic imaging modality.
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